Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice

BACKGROUND: Bone strength is impaired in patients with type 2 diabetes mellitus despite an increase in bone mineral density (BMD). Thiazolidinedione (TZD), a peroxisome proliferator activated receptor γ agonist, promotes adipogenesis, and suppresses osteoblastogenesis. Therefore, its use is associat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Endocrinol Metab (Seoul)
Main Authors: Kim, Kyoung Min, Jin, Hyun-Jin, Lee, Seo Yeon, Maeng, Hyo Jin, Lee, Gha Young, Oh, Tae Jung, Choi, Sung Hee, Jang, Hak Chul, Lim, Soo
Formato: Artigo
Idioma:Inglês
Publicado: Korean Endocrine Society 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620037/
https://ncbi.nlm.nih.gov/pubmed/28956370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2017.32.3.389
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares